Company / Net Debt per Share
IGC Pharma, Inc. Net Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$0.00
FY2025
5-year range
-$0.22 / -$0.00
FY2021-FY2025
Trend
+83.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Debt per Share has increased for 3 consecutive years, from $-0.22 in FY2022 to $-0.00 in FY2025.
Based on SEC 10-K filings.
-0.00 in FY2025.
Increased from $-0.06 to $-0.00 over the past 2 years.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- IGC Pharma, Inc.'s net debt per share has grown for 3 consecutive years.
- In FY2025, net debt per share increased 83.2% year-over-year.
- Lowest net debt per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -13.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.00 | +83.2% |
| FY2024 | -$0.02 | +66.6% |
| FY2023 | -$0.06 | +72.3% |
| FY2022 | -$0.22 | -21.5% |
| FY2021 | -$0.18 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | -$0.04 | -151.8% |
| FY2016 | -$0.02 | +96.7% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026